- US-listed companies
- BICYCLE THERAPEUTICS PLC
- Income statement
BICYCLE THERAPEUTICS PLC (BCYC) Income statement
Market cap
$349.73M
P/E ratio
| 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 14 | 10 | 12 | 14 | 27 | 35 |
| Revenue growth (%) | - | |||||
| Research & development | 26 | 33 | 45 | 82 | 156 | 173 |
| Operating margin (%) | ||||||
| Operating expenses | 40 | 62 | 77 | 131 | 217 | 245 |
| Operating income | -26 | -52 | -66 | -117 | -190 | -210 |
| Income before tax | -31 | -52 | -68 | -114 | -179 | -174 |
| Pretax margin (%) | -223.6 | -497.9 | -585.5 | -789.9 | -664.3 | -492.7 |
| Provision for income taxes | -0 | -1 | -2 | -1 | 2 | -5 |
| Effective tax rate (%) | ||||||
| Net income | -31 | -51 | -67 | -113 | -181 | -169 |
| Net income margin (%) | ||||||
| Earnings per share | - | - | -2.67 | -3.8 | -5.08 | -2.9 |
| Diluted EPS | - | - | -2.67 | -3.8 | -5.08 | -2.9 |
| EBITDA | ||||||
| EBITDA margin (%) |